Added value of PET and PET–CT in oesophageal cancer: a review of current practice
- 1 January 2008
- journal article
- review article
- Published by Wolters Kluwer Health in Nuclear Medicine Communications
- Vol. 29 (1) , 4-10
- https://doi.org/10.1097/mnm.0b013e3282f1b9c7
Abstract
Oesophageal carcinoma is a relatively rare form of cancer. However, it is also one of the most deadly forms of cancer, with a 5-year survival rate of only 3% for patients with nodal disease, and 42% for those without nodal disease. It is therefore very important to accurately stage the disease at diagnosis and before therapy. In this article, we review the role of commonly used investigative techniques in the diagnosis and staging of oesophageal carcinoma, with special emphasis on PET and PET-CT scanning. The literature is reviewed in the context of our recent experience. A retrospective review of 129 patients with oesophageal carcinoma, who underwent PET or PET-CT scanning over a 24-month period confirmed the incremental value of PET and PET-CT scanning in the staging of oesophageal carcinoma.Keywords
This publication has 23 references indexed in Scilit:
- The homeodomain protein CDX2 is an early marker of Barrett’s oesophagusJournal of Clinical Pathology, 2004
- Impact of lymph node staging on therapy of esophageal carcinomaGastroenterology, 2003
- The role of endoscopy in the assessment and treatment of esophageal cancerGastrointestinal Endoscopy, 2003
- Chromosome 4 hyperploidy represents an early genetic aberration in premalignant Barrett's oesophagusGut, 2003
- A systematic review of the staging performance of endoscopic ultrasound in gastro-oesophageal carcinomaGut, 2001
- Imaging Features of Primary and Recurrent Esophageal Cancer at FDG PETRadioGraphics, 2000
- Evaluation of metastatic celiac axis lymph nodes in patients with esophageal carcinoma: accuracy of EUSGastrointestinal Endoscopy, 1999
- Carcinoma of the esophagus and esophagogastric junction: sensitivity of radiographic diagnosis.American Journal of Roentgenology, 1997
- Klinische Überprüfung des Tumormarkers CA 19-9 im Vergleich zum karzinoembryonalen Antigen (CEA) in der chirurgischen prä- und postoperativen DiagnostikNuklearmedizin-Nuclear Medicine, 1986
- Oesophageal cancer in IndiaZeitschrift für Krebsforschung und Klinische Onkologie, 1981